We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Tevogen Bio is a leading NextGen clinical-stage specialty immunotherapy Biotech developing off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Tevogen Bio is a leading NextGen clinical-stage specialty immunotherapy Biotech developing off-the-shelf precision T cell therapeutics in virology, oncology, and neurology.
Listing on Nasdaq is expected to provide Tevogen Bio Holdings Inc. increased access to capital to accelerate development of its genetically unmodified off-the-shelf T cell therapy products for...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 1.41 | 30.0639658849 | 4.69 | 11.05 | 4.69 | 140 | 6.72613365 | CS |
26 | -4.85 | -44.2922374429 | 10.95 | 11.44 | 4.69 | 142 | 9.33991992 | CS |
52 | -4.48 | -42.3440453686 | 10.58 | 11.97 | 4.69 | 1070 | 10.59641722 | CS |
156 | -3.97 | -39.4240317776 | 10.07 | 12.45 | 4.69 | 33879 | 10.10150554 | CS |
260 | -3.97 | -39.4240317776 | 10.07 | 12.45 | 4.69 | 33879 | 10.10150554 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions